U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER
333-03618
CUSIP NUMBER
71941T 10 9 (Class A)
CUSIP NUMBER
71941T 20 8 (Class B)
(Check One):
[X] Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-QSB [ ] Form N-SAR
For Period Ended: December 31, 1996
-----------------------------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ______________
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: [N/A]
PART I--REGISTRATION INFORMATION
Full Name of Registrant: Physicians Information Exchange, Inc.
Former Name if Applicable: [N/A]
Address of Principal Executive Office (Street and Number)
1401 Hudson Lane
Suite 202
Monroe, Louisiana 71201
(City, State and Zip Code)
CORPDAL:63678.1 29375-00001
<PAGE>
PART II--RULES 12B-25 (B) AND (C)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b- 25(b), the following
should be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K, 10-QSB or N-SAR, or portion thereof will be
filed on or before the fifteenth calendar day following the prescribed due date;
or the subject quarterly report or transition report on Form 10-Q, or portion
thereof, will be filed on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III--NARRATIVE
State below in reasonable detail the reasons why annual report, quarterly
report, transition report on Form 10-K, 20-F, 11-K, 10-QSB or N-SAR or portion
thereof could not be filed within the prescribed period.
The Company has recently engaged in discussions with several entities
and individuals in connection with an expansion of the Company's operations and
senior management has not finalized the compilation of the information necessary
to complete the Form 10-KSB.
PART IV--OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to
this notification
DR. W. ERNEST RUTHERFORD (318) 387-5253
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
[The Rest of this Page is Intentionally Blank]
CORPDAL:63678.1 29375-00001
<PAGE>
Physicians Information Exchange, Inc.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 31, 1997 By: /s/ Dr. W. Ernest Rutherford
-------------------------------
Dr. W. Ernest Rutherford, Chairman, Chief
Executive Officer and President
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be field with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
CORPDAL:63678.1 29375-00001
